Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_assertion type Assertion NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_head.
- NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_assertion description "[In total, 2,351 patients with MDS who have records in the German-Austrian and the MD Anderson Cancer Center databases were included and analyzed in univariate and multivariate models regarding overall survival and risk of transformation to acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_provenance.
- NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_assertion evidence source_evidence_literature NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_provenance.
- NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_assertion SIO_000772 21519021 NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_provenance.
- NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_assertion wasDerivedFrom befree-20150227 NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_provenance.
- NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_assertion wasGeneratedBy ECO_0000203 NP781602.RA0JOj7UPv2frxxNV-NoJZkXNJKyBSTMYCRxwDVu4OSBs130_provenance.